Since 1993, the Convention on Biological Diversity (CBD) has regulated access to genetic resources and in October 2014, the Nagoya Protocol (NP), which provides a defined legal framework for the CBD, went into effect across the EU Member States (EU Regulation 511/2014) and the United Kingdom subsequently passed implementing legislation. These laws deal with the accession and distribution of all genetic resources i.e. biological material.
Compliance with the Nagoya Protocol
Please review your legal situation before beginning the depositing process.
The Nagoya Protocol legislation may apply if the sample you wish to send:
- was collected on or after the 12 October 2014 and
- was collected from a country that is party to the NP. You can check this information by visiting Access and Benefit Sharing Clearing House (ABSCH).
Documentation and Due Diligence
If your samples have been collected after the 12 October 2014 and your country is part of the NP, extra documentation will be required. Those documents i.e. the Prior Informed Consent (PIC), the Mutually Agreed Terms (MAT) and/or the Material Transfer Agreement (MTA) are provided by the Competent National Authorities (CNA) or the ABS National Focal Points (NFP) of each country (list available here).
These documents prove that the material was legally accessed and may also determine permitted uses and terms of benefit sharing. Copies of the documents must be transferred along with the material.
Please, if you’re unsure or if you need any help, feel free to get in touch with us at firstname.lastname@example.org in order to clarify any requirement.
Main information website
- The Convention on Biological Diversity
- The Nagoya Protocol on Access and Benefit-sharing
- The Access and Benefit-sharing Clearing-house (ABSCH) is a platform for exchanging information on ABS and a key tool for facilitating the implementation of the Nagoya Protocol